
Noble E. Jarrell
Examiner (ID: 14167, Phone: (571)272-9077 , Office: P/1625 )
| Most Active Art Unit | 1699 |
| Art Unit(s) | 1625, 1699, 1622, 1624, 1609 |
| Total Applications | 1419 |
| Issued Applications | 950 |
| Pending Applications | 180 |
| Abandoned Applications | 334 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18628092
[patent_doc_number] => 20230286917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => HISTONE DEMETHYLASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/126327
[patent_app_country] => US
[patent_app_date] => 2023-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18126327
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/126327 | HISTONE DEMETHYLASE INHIBITORS | Mar 23, 2023 | Pending |
Array
(
[id] => 19186208
[patent_doc_number] => 20240165121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => SUBSTITUTED BENZENE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/188700
[patent_app_country] => US
[patent_app_date] => 2023-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18188700
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/188700 | SUBSTITUTED BENZENE COMPOUNDS | Mar 22, 2023 | Pending |
Array
(
[id] => 18649324
[patent_doc_number] => 20230295113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => NLRP3 MODULATORS
[patent_app_type] => utility
[patent_app_number] => 18/183856
[patent_app_country] => US
[patent_app_date] => 2023-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18183856
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/183856 | NLRP3 MODULATORS | Mar 13, 2023 | Pending |
Array
(
[id] => 19003579
[patent_doc_number] => 20240067650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => MACROCYCLIC LIGANDS WITH PENDANT CHELATING MOIETIES AND COMPLEXES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/182147
[patent_app_country] => US
[patent_app_date] => 2023-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18182147
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/182147 | MACROCYCLIC LIGANDS WITH PENDANT CHELATING MOIETIES AND COMPLEXES THEREOF | Mar 9, 2023 | Pending |
Array
(
[id] => 18647767
[patent_doc_number] => 20230293538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => Methods for the Prevention and Treatment of Hearing Loss
[patent_app_type] => utility
[patent_app_number] => 18/117852
[patent_app_country] => US
[patent_app_date] => 2023-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18117852
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/117852 | Methods for the prevention and treatment of hearing loss | Mar 5, 2023 | Issued |
Array
(
[id] => 20213620
[patent_doc_number] => 12410262
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => Peptide conjugates of cytotoxins as therapeutics
[patent_app_type] => utility
[patent_app_number] => 18/174981
[patent_app_country] => US
[patent_app_date] => 2023-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 16
[patent_no_of_words] => 31578
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 220
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18174981
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/174981 | Peptide conjugates of cytotoxins as therapeutics | Feb 26, 2023 | Issued |
Array
(
[id] => 19081806
[patent_doc_number] => 20240108607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => METHOD FOR MANUFACTURING NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF AND MANUFACTURING INTERMEDIATE OF NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/112423
[patent_app_country] => US
[patent_app_date] => 2023-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22283
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18112423
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/112423 | METHOD FOR MANUFACTURING NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF AND MANUFACTURING INTERMEDIATE OF NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF | Feb 20, 2023 | Abandoned |
Array
(
[id] => 18829701
[patent_doc_number] => 20230398225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => PD-L1/STING CONJUGATES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/092610
[patent_app_country] => US
[patent_app_date] => 2023-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18092610
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/092610 | PD-L1/STING CONJUGATES AND METHODS OF USE | Jan 2, 2023 | Pending |
Array
(
[id] => 18484829
[patent_doc_number] => 20230212136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => CURABLE RESIN COMPOSITION, CURED PRODUCT, DIFFRACTIVE OPTICAL ELEMENT, AND MULTILAYER DIFFRACTIVE OPTICAL ELEMENT
[patent_app_type] => utility
[patent_app_number] => 18/091139
[patent_app_country] => US
[patent_app_date] => 2022-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18091139
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/091139 | CURABLE RESIN COMPOSITION, CURED PRODUCT, DIFFRACTIVE OPTICAL ELEMENT, AND MULTILAYER DIFFRACTIVE OPTICAL ELEMENT | Dec 28, 2022 | Pending |
Array
(
[id] => 18626774
[patent_doc_number] => 20230285581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => RIFAMYCIN ANALOGS AND ANTIBODY-DRUG CONJUGATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/090138
[patent_app_country] => US
[patent_app_date] => 2022-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 105947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18090138
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/090138 | RIFAMYCIN ANALOGS AND ANTIBODY-DRUG CONJUGATES THEREOF | Dec 27, 2022 | Pending |
Array
(
[id] => 19954411
[patent_doc_number] => 12324808
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-10
[patent_title] => Methods for the prevention and treatment of hearing loss
[patent_app_type] => utility
[patent_app_number] => 18/084033
[patent_app_country] => US
[patent_app_date] => 2022-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 0
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18084033
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/084033 | Methods for the prevention and treatment of hearing loss | Dec 18, 2022 | Issued |
Array
(
[id] => 18753871
[patent_doc_number] => 20230357180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => DEGRADERS AND DEGRONS FOR TARGETED PROTEIN DEGRADATION
[patent_app_type] => utility
[patent_app_number] => 18/079815
[patent_app_country] => US
[patent_app_date] => 2022-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 990
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18079815
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/079815 | DEGRADERS AND DEGRONS FOR TARGETED PROTEIN DEGRADATION | Dec 11, 2022 | Pending |
Array
(
[id] => 19233641
[patent_doc_number] => 20240190833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => FRACTIONATION OF CANNABIS EXTRACTS
[patent_app_type] => utility
[patent_app_number] => 18/078216
[patent_app_country] => US
[patent_app_date] => 2022-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3927
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18078216
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/078216 | FRACTIONATION OF CANNABIS EXTRACTS | Dec 8, 2022 | Pending |
Array
(
[id] => 18672975
[patent_doc_number] => 20230310432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => CONTROL AND MODULATION OF THE FUNCTION OF GENE-MODIFIED CHIMERIC ANTIGEN RECEPTOR T CELLS WITH DASATINIB AND OTHER TYROSINE KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/058347
[patent_app_country] => US
[patent_app_date] => 2022-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33257
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18058347
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/058347 | CONTROL AND MODULATION OF THE FUNCTION OF GENE-MODIFIED CHIMERIC ANTIGEN RECEPTOR T CELLS WITH DASATINIB AND OTHER TYROSINE KINASE INHIBITORS | Nov 22, 2022 | Pending |
Array
(
[id] => 18391289
[patent_doc_number] => 20230159507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => MODULATORS OF HEMOGLOBIN
[patent_app_type] => utility
[patent_app_number] => 17/991448
[patent_app_country] => US
[patent_app_date] => 2022-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17991448
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/991448 | MODULATORS OF HEMOGLOBIN | Nov 20, 2022 | Pending |
Array
(
[id] => 19135564
[patent_doc_number] => 11970494
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/982663
[patent_app_country] => US
[patent_app_date] => 2022-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63423
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17982663
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/982663 | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors | Nov 7, 2022 | Issued |
Array
(
[id] => 18770736
[patent_doc_number] => 20230365514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => MACROCYCLIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/962152
[patent_app_country] => US
[patent_app_date] => 2022-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59767
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 957
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17962152
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/962152 | MACROCYCLIC COMPOUNDS | Oct 6, 2022 | Pending |
Array
(
[id] => 18830990
[patent_doc_number] => 20230399515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => PHTHALOCYANINE DYE COMPOUNDS, CONJUGATES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/934705
[patent_app_country] => US
[patent_app_date] => 2022-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47310
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934705
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/934705 | Phthalocyanine dye compounds, conjugates and methods of use thereof | Sep 22, 2022 | Issued |
Array
(
[id] => 20173099
[patent_doc_number] => 12391832
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Color matched and bright fluorescent materials composed of small-molecule ionic lattices
[patent_app_type] => utility
[patent_app_number] => 17/942127
[patent_app_country] => US
[patent_app_date] => 2022-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 42
[patent_no_of_words] => 9543
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17942127
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/942127 | Color matched and bright fluorescent materials composed of small-molecule ionic lattices | Sep 9, 2022 | Issued |
Array
(
[id] => 18321419
[patent_doc_number] => 20230119547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => DI-SUBSTITUTED PYRAZOLE COMPOUNDS FOR THE TREATMENT OF DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/940640
[patent_app_country] => US
[patent_app_date] => 2022-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50565
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17940640
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/940640 | DI-SUBSTITUTED PYRAZOLE COMPOUNDS FOR THE TREATMENT OF DISEASES | Sep 7, 2022 | Pending |